Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Schmierer

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Abhandlungen Zur Geschichte Der Medizin Und Der Naturwissenschaften|July 20, 2002
[Medical history and politics: careers of Fritz Lejeune during the Weimar Republic and national socialism]Klaus Schmierer
Brain Pathology (Zurich, Switzerland)|August 30, 2023
Honing in on magnetic resonance imaging predictors of multiple sclerosis pathologyKlaus Schmierer
Brain Pathology (Zurich, Switzerland)|April 15, 2020
B cells and multiple sclerosis spinal cord pathologyKlaus Schmierer, David Baker
Acta Neuropathologica|May 8, 2024
The shoulders we keep standing on: remembering Otto Marburg, a big brain in neurology and multiple sclerosis, at 150Klaus Schmierer, Hans Lassmann
Brain Pathology (Zurich, Switzerland)|October 31, 2018
Magnetic resonance imaging correlates of neuro-axonal pathology in the MS spinal cordKlaus Schmierer, Marc E Miquel
Multiple Sclerosis and Related Disorders|November 17, 2017
Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatmentDavid Baker, Gavin Giovannoni, Klaus Schmierer
The Lancet. Neurology|July 25, 2003
Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitisPascal Grosse, Joachim Schulz, Klaus Schmierer
Lancet (London, England)|September 16, 2014
Simvastatin in patients with progressive multiple sclerosisGavin Giovannoni, David Baker, Klaus Schmierer
Multiple Sclerosis and Related Disorders|March 20, 2015
The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?Gavin Giovannoni, David Baker, Klaus Schmierer
JAMA Neurology|May 26, 2018
No Evident Disease Activity-More Than a Risky Ambition?Benjamin Meir Jacobs, Gavin Giovannoni, Klaus Schmierer
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Abhandlungen Zur Geschichte Der Medizin Und Der Naturwissenschaften|July 20, 2002
[Medical history and politics: careers of Fritz Lejeune during the Weimar Republic and national socialism]Klaus Schmierer
Brain Pathology (Zurich, Switzerland)|August 30, 2023
Honing in on magnetic resonance imaging predictors of multiple sclerosis pathologyKlaus Schmierer
Brain Pathology (Zurich, Switzerland)|April 15, 2020
B cells and multiple sclerosis spinal cord pathologyKlaus Schmierer, David Baker
Acta Neuropathologica|May 8, 2024
The shoulders we keep standing on: remembering Otto Marburg, a big brain in neurology and multiple sclerosis, at 150Klaus Schmierer, Hans Lassmann
Brain Pathology (Zurich, Switzerland)|October 31, 2018
Magnetic resonance imaging correlates of neuro-axonal pathology in the MS spinal cordKlaus Schmierer, Marc E Miquel
Multiple Sclerosis and Related Disorders|November 17, 2017
Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatmentDavid Baker, Gavin Giovannoni, Klaus Schmierer
The Lancet. Neurology|July 25, 2003
Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitisPascal Grosse, Joachim Schulz, Klaus Schmierer
Lancet (London, England)|September 16, 2014
Simvastatin in patients with progressive multiple sclerosisGavin Giovannoni, David Baker, Klaus Schmierer
Multiple Sclerosis and Related Disorders|March 20, 2015
The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?Gavin Giovannoni, David Baker, Klaus Schmierer
JAMA Neurology|May 26, 2018
No Evident Disease Activity-More Than a Risky Ambition?Benjamin Meir Jacobs, Gavin Giovannoni, Klaus Schmierer
Pageof 13